No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study

Acta Dermato-venereologica
Maren WeischerMark Berneburg

Abstract

Phototherapy of skin diseases such as psoriasis is an effective and safe treatment modality. However, increasing the risk of skin cancer by phototherapy is a serious concern. An increased skin cancer risk occurs after prolonged photochemotherapy (PUVA). In contrast, the role of broadband UVB or narrowband UVB therapy in skin carcinogenesis of humans with psoriasis is less clear. Therefore, we investigated the incidence of skin tumours in a total of 195 psoriasis patients, receiving broadband (n=69) or narrowband (n=126) UVB from 1994 to 2000 with follow-up until 2003. Data were raised from the regional interdisciplinary cancer centre of the University of Tuebingen, Germany and compared with the tumour incidences given for the German population. In this study, with 80% statistical power to detect a 6-7-fold increase in skin cancer with broadband UVB and 83% power to detect a 5-6-fold increase with narrow band UVB at p=0.05, only one patient developed skin cancer - an in situ melanoma. The tumour occurred within the same year that phototherapy was initiated. Thus, the present study does not provide evidence for an increased skin cancer risk for patients treated with either broadband or narrowband UVB phototherapy

Citations

Apr 26, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·G Hofbauer
Jan 15, 2009·Archives of Dermatological Research·Thilo Gambichler
Apr 13, 2005·Acta Dermato-venereologica·Mark BerneburgFrauke Benedix
Jun 27, 2009·Journal of Toxicology and Environmental Health. Part a·Anna BrozynaBarbara W Chwirot
Jan 6, 2012·Journal of Allergy·Sonja Alexandra Grundmann, Stefan Beissert
Aug 12, 2006·Dermatology : International Journal for Clinical and Investigative Dermatology·Simone Maria GoldingerSeverin Lauchli
Jan 1, 2010·Clinical, Cosmetic and Investigational Dermatology·Hobart W Walling, Brian L Swick
Nov 17, 2010·Indian Journal of Dermatology, Venereology and Leprology·Sunil Dogra, Dipankar De
May 28, 2013·ISRN Dermatology·Fabrizio AyalaPaolo A Ascierto
Nov 22, 2014·Dermatologic Clinics·Emoke Racz, Errol P Prens
Nov 10, 2009·The Journal of Dermatological Treatment·Rupa PugashettiJohn Koo
Jan 30, 2016·The Journal of Dermatological Treatment·Alessia MaiorinoKetty Peris
Feb 22, 2012·Expert Review of Anti-infective Therapy·Tianhong DaiMichael R Hamblin
Mar 10, 2016·Indian Journal of Dermatology·Hayedeh Ghani-NejadSara Beigi
Apr 5, 2011·Journal of the American Academy of Dermatology·Yi-Ju ChenYun-Ting Chang
Jun 29, 2010·Seminars in Cutaneous Medicine and Surgery·Rupa Pugashetti, John Koo
Jun 19, 2009·Journal of the American Academy of Dermatology·Bruce StroberMelodie Young
Apr 7, 2009·Journal of the American Academy of Dermatology·Rita V PatelJeffrey M Weinberg
Jan 23, 2009·Journal of the American Academy of Dermatology·Electra NicolaidouAndreas D Katsambas
Aug 10, 2007·The Journal of Investigative Dermatology·Makoto KunisadaChikako Nishigori
Mar 24, 2007·The Journal of Investigative Dermatology·Sandra M KirkePeter M Farr
Jun 18, 2010·The Journal of Investigative Dermatology·Leanne M Johnson-HuangMichelle A Lowes
Apr 21, 2005·The British Journal of Dermatology·I ManJ Ferguson
Oct 20, 2005·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Mark BerneburgMartin Röcken
May 15, 2009·Photodermatology, Photoimmunology & Photomedicine·In-Ho KwonJai-Il Youn
Jun 8, 2007·The British Journal of Dermatology·B L Diffey, P M Farr
Oct 7, 2008·The British Journal of Dermatology·R M R HearnR S Dawe
Jul 31, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·J C SitekJ R Ronnevig
Nov 8, 2007·Photodermatology, Photoimmunology & Photomedicine·V BrazzelliG Borroni
Feb 1, 2006·The British Journal of Dermatology·R J Black, A T Gavin
Nov 26, 2005·The British Journal of Dermatology·A XifraC Ferrándiz
Apr 25, 2012·The British Journal of Dermatology·K K ParkJ E Murase
May 26, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·E ArchierM-A Richard
Sep 29, 2011·Photodermatology, Photoimmunology & Photomedicine·Alessia Pacifico, Giovanni Leone
Sep 29, 2012·Photodermatology, Photoimmunology & Photomedicine·Chanisada Wongpraparut, Piyaroj Setabutra
Oct 27, 2010·The British Journal of Dermatology·T GambichlerA Kreuter
Feb 9, 2010·Dermatologic Therapy·Robert J Sage, Henry W Lim
May 5, 2010·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Eleni Iordanou, Mark Berneburg
Sep 17, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·P ZamberkP Lázaro
Mar 25, 2010·Lasers in Surgery and Medicine·Emoke RáczErrol P Prens
Aug 2, 2008·Journal of Cellular and Molecular Medicine·David MitchellAndrea Koreck

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.